Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05293912 |
Title | SG2501 Safety Study in Subjects With Relapsed or Refractory Hematological Malignancies and Lymphoma. |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Hangzhou Sumgen Biotech Co., Ltd. |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Northside Hospital | RECRUITING | Atlanta | Georgia | 30342 | United States | Details |
John Theurer Cancer Center at Hackensack UMC | RECRUITING | Hackensack | New Jersey | 07601 | United States | Details |
Westchester Medical Center | NOT_YET_RECRUITING | Hawthorne | New York | 10532 | United States | Details |
Novant Health Forsyth Medical Center | RECRUITING | Charlotte | North Carolina | 27103 | United States | Details |
Duke University | NOT_YET_RECRUITING | Durham | North Carolina | 27705 | United States | Details |
Novant Health Cancer Institute Hematology - Forsyth | RECRUITING | Winston-Salem | North Carolina | 27103 | United States | Details |
Gabrail Cancer Center Research, LLC | RECRUITING | Canton | Ohio | 44718 | United States | Details |
Texas Oncology / Baylor Charles A. Sammons Cancer Center | NOT_YET_RECRUITING | Dallas | Texas | 75246 | United States | Details |